Dr. Natasha Hunter Named 2026 Athena Endowed Award Recipient

Photo Credits: Fred Hutch

Dr. Natasha (Tasha) Hunter, Cancer Vaccine Institute Director of Clinical Trials, has been selected as the recipient of the 2026 Athena Endowed Award for Excellence in Breast Cancer Research. The Athena Award was established to recognize an early career researcher making the greatest contribution during the past year toward advancing research to improve the prevention, detection, diagnosis and/or treatment of breast cancer.

Read more about Dr. Hunter here.

PC: Fred Hutch